Next-generation sequencing of iron-metabolism related genes in Portuguese patients with iron overload: novel pathogenic genetic variants by Faria, Ricardo et al.
Next-generation sequencing of iron metabolism-related genes in  
Portuguese patients with iron overload: novel pathogenic genetic variants  
 Faria R.1, Silva B.1, Silva C.1, Vieira L.1, Loureiro P.1, Gomes S.1, Gonçalves J.1, Rivera I.2, Fraga S.3, Fleming R.4, Faustino P.1 
 
(1)   J. N. Feder,  et al.  A novel MHC class-I gene is mutated in patients with hereditary haemochromatosis.  
 Nat. Genetics 13 (1996) 399-408.  
(2)   A. T.  Merryweather-Clarke, et al. Geography of HFE C282Y and H63D. 
 Genet. Test. 4 (2000) 183-198. 
(3)  B. Silva, P. Faustino. An overview of molecular basis of iron metabolism regulation and the associated pathologies.  
BBA 1852 (2015) 1347-1359. 
Eighty-eight iron overload Portuguese patients, negative for the common HFE risk genotypes 
were analysed by NGS for six iron metabolism-related genes (HFE, TFR2, HAMP, HJV, SLC40A1 
and FTL).  
A TruSeq Custom Amplicon kit (TSCA, by Illumina) was designed in order to generate 97 
amplicons covering exons, intron/exon junctions and UTRs of the mentioned genes with a 
cumulative target sequence of 12115bp. Amplicons were sequenced in the MiSeq instrument 
(IIlumina) using 250 bp paired-end reads. Sequences were aligned against human genome 
reference hg19 using alignment and variant caller algorithms in the MiSeq reporter software 
(Illumina).  
Novel and very rare variants were validated by Sanger sequencing (Applied Biosystems) and 
their pathogenic significance were assessed by in silico studies (Polyphen-2, Human Splicing 
Finder).  
A total of 1242 genetic alterations (corresponding to 55 different variants) 
were found by NGS in the 88 Portuguese non-classical HH patients. Fourteen 
of them are presented in Table I. These include three novel mutations in TFR2 
[two missense (p.Leu750Pro and p.Ala777Val) and one intronic splicing 
mutation (c.967-1 G>C)] (Fig.1), one novel missense mutation in HFE 
(p.Tyr230Cys), one private mutation at the 5’-UTR of HAMP (c.-25 G>A) which 
gives rise to a premature translation initiation codon, and two mutations in 
the Iron-Responsive Element (IRE) of FTL gene, c.-173C>G and c.-167C>A 
(Fig.2). 
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The recent development of NGS allows practical, manageable, and cost-effective analysis of the non-classic HH cases, proving to have significant utility 
when conventional testing has failed to identify the underlying molecular basis of the disease. However, establishing the clinical relevance of NGS-
detected variants for HH development remains a hard-working task, requiring further functional studies. 
The identification and study of novel iron metabolism-related mutations are important steps forward to improve the knowledge of the HH genetic basis 
heterogeneity and of the pathophysiology of the different types of HH. Clinically, it is also important because whilst the treatment of the more common 
forms of iron overload is similar, differential diagnosis remains important in atypical cases in which specific treatment and/or monitoring options are 
recommended. 
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Chr6:26092985A>G HFE 430:455 het 9069.08 Exon 4 c.689A>G p.(Tyr230Cys) 
Missense; 
Possibly Damaging 
Chr6:26092801T>C HFE 57:66 het 1325.07 Intron 3 c.617-112T>C - Likely benign 
Chr7:100229569C>G TFR2 0:453 hom 10655.17 Intron 7 c.967-1G>C - 
Affects splicing; 
Possibly Damaging 
Chr7:100218637A>G TFR2 4:215 hom 4960.62 Exon 18 c.2249T>C p.(Leu750Pro) 
Missense; 
Probably damaging 
Chr7:100218556G>A TFR2 
Case 1: 141:116 
Case 2: 141:146 
het 
het 
2236.37 
4408.53 
Exon 18 c.2330C>T p.(Ala777Val) 
Missense; 
Probably damaging 
Chr19:35773456G>A HAMP 
Case 1: 0:394 
Case 2: 2:476 
hom 
hom 
15985.68 
19146.68 
5’UTR c.-25G>A - 
Alters ORF; 
Pathogenic 
Chr19:35773318G>A HAMP 62:49 het 874.57 5’UTR c.-92G>A - Likely benign 
Chr1:145414708G>A HJV 240:218 het 4285.30 5’UTR c.-74C>T - Likely benign 
Chr1:145415253G>A HJV 47:44 het 814.49 Intron 3 c.1002-26C>T - Likely benign 
Chr1:145415769A>G HJV 59:62 het 1198.75 Exon 4 c.932T>C p.(Asn129=) 
Synonymous/ 
Likely benign 
Chr2:190436342A>G SLC40A1 242:180 het 3470.70 Intron 5 c.514+99T>C - Likely benign 
Chr19:49468592C>G FTL 39:36 het 653.68 IRE_ 5’UTR c.-173C>G - Possibly Pathogenic 
Chr19:49468598C>A FTL 24:25 het 472.00 IRE_ 5’UTR c.-167C>A - Pathogenic 
Chr19:49469233T>G FTL 138:164 het 3347.00 Intron 2 c.249+60T>G - Likely benign 
Fig. 1 - Sanger sequencing electropherograms with validation of the novel pathogenic variants 
detected by NGS in TFR2 gene:  
A) homozygosity for the TFR2:c.967-1G>C; B) homozygosity for the TFR2:c.2249T>C, 
p.(Leu750Pro);  C) heterozygosity for the TFR2:c.2330C>T, p.(Ala777Val) - this patient is a 
double heterozygous for the mentioned variant and the HFE:c.187C>G,p.(His63Asp). 
Fig. 2 - Sanger sequencing 
electropherogram showing the  
 c.-167C>A variant in heterozygosity. 
It is located in the IRE of FTL gene and 
was found in segregation in a family 
in association with hereditary 
hyperferritinemia with congenital 
cataracts. 
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Hereditary Hemochromatosis (HH) is an autosomal recessive disorder characterized by excessive intestinal iron absorption resulting in pathologically increased body iron stores. 
It is typically associated with a common HFE gene mutation (p.Cys282Tyr)(1). However, particularly in Southern European populations, around one third of the patients with 
primary iron overload do not present that genotype or the compound heterozygosity for the p.Cys282Tyr and the p.His63Asp mutations (2). In fact, in addition to HFE, other iron 
metabolism-related genes may be involved in HH development (3). 
This study aimed to explore the use of the Next-Generation Sequencing (NGS) technology for rapid and simultaneous analysis of a panel of six iron metabolism-related genes 
(HFE, TFR2, HJV, HAMP, SLC40A1, and FTL) in 88 Portuguese patients with persistent iron overload, not exposed to environmental factors known to promote this phenotype, and 
a negative HFE-HH-first level genetic test.  
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C) Patient: 36-year-old woman;  
Fe= 236 g/dL;  
Tranf. Sat. = 86%.  
A) Patient: 69-year-old man;  
 Fe = 198 g/dL; Ft = 1930 ng/mL; 
Tranf. Sat. = 100% 
B) Patient: 56-year-old man;  
Fe = 260 g/dL; Ft = 2961 ng/mL; 
Tranf. Sat. = 84% 
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